Acorda Therapeutics Company
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Investors
%20.jpg)
Founded Date:
1995
Investor Type:
Company
Employee Number:
251-500
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Immunotherapy
Industry:
Loss of Proteostasis
Headquarters:
United States
Estimated Revenue:
$50M to $100M